Geoff Poole
Papers
2
Total Citations
249
H-Index
2
About
Geoff Poole is a leading researcher in fetal medicine and transfusion science, whose work has revolutionized the management of RhD-negative pregnancies. His primary research focuses on non-invasive prenatal testing, specifically the high-throughput genotyping of fetal DNA from maternal plasma to determine the fetal RhD blood group. Poole’s landmark 2008 prospective feasibility study, which has garnered over 230 citations, demonstrated that automated robotic techniques could accurately predict fetal RhD status, thereby sparing RhD-negative women from unnecessary anti-RhD immunoglobulin injections. This contribution directly addresses the prevention of hemolytic disease of the fetus and newborn, a condition historically caused by RhD alloimmunization. By enabling mass antenatal screening, Poole’s work has significantly reduced the use of scarce blood products and improved patient outcomes. His research bridges clinical practice and laboratory innovation, offering a cost-effective, scalable solution that has been adopted in prenatal care protocols worldwide. For students and researchers, Poole exemplifies how translational science can transform routine obstetrics, combining molecular diagnostics with public health impact.
Research Focus
Key Achievements
Top Papers
- 1
- 2